 |
|
Brain Tumors in the Elderly
Recent Trends in a Minnesota Cohort Study
Jeanette K. Lowry, MD;
Jon J. Snyder, MS;
Philip W. Lowry, MD
Arch Neurol. 1998;55:922-928.
Objective To compare the clinical presentation, time elapsed to diagnosis, and survival of elderly patients ( 65 years) with that in younger patients with malignant primary brain tumors.
Design Retrospective cohort study.
Setting Four hospitals in Minneapolis, Minn.
Patients Seven hundred fourteen patients diagnosed as having and treated for primary malignant brain tumors between 1980 and 1995; 230 (32%) were 65 years or older.
Main Outcome Measures The type and duration of the chief presenting symptom, the time elapsed to diagnosis, the treatment modalities used, and patient survival were analyzed.
Results Time elapsed from onset of symptom to diagnosis was not longer for elderly patients than younger ones, with the exception of patients aged 18 to 24 years, who had a significantly longer delay in diagnosis (P=.004). Elderly patients were significantly less likely to present with headache or seizure (P<.001), and more likely to present with confusion, aphasia, or memory loss (for each, P<.001). With the single exception of confusion, the duration of all other presenting symptoms was not significantly longer for patients 65 years and older compared with younger patients. Survival is significantly reduced in older patients, and appears to worsen significantly in patients 45 years and older (P<.001). A significantly higher proportion of patients 65 years and older with glioblastoma multiforme received no treatment (P=.004) if diagnosed after 1990.
Conclusions Elderly patients (65 years) with malignant brain tumors are diagnosed as promptly as younger patients, although they have a markedly different constellation of symptoms. Since diagnosis of brain tumors continues to improve in the elderly, it may be more difficult to ascribe the steady increase in incidence to artifactual factors.
From the Department of Medicine, Medical School (Drs J. K. Lowry and P. W. Lowry), and the Divisions of Biostatistics (Mr Snyder) and Epidemiology (Dr P. W. Lowry), School of Public Health, University of Minnesota, Rochester. Dr P. W. Lowry is now with Mayo Clinic, Rochester.
RELATED ARTICLE
Brain Tumors in the Elderly: Undefeated and Gaining Ground
Hassan M. Fathallah-Shaykh and Donald D. McIntire
Arch Neurol. 1998;55(7):905-906.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2-Deficient Mouse Astrocytoma
Marsh et al.
Clin. Cancer Res. 2008;14:7751-7762.
ABSTRACT
| FULL TEXT
Darts in the Dark Cure Animal, but Not Human, Brain Tumors
Fathallah-Shaykh
Arch Neurol 2002;59:721-724.
FULL TEXT
Brain Tumors in the Elderly: Undefeated and Gaining Ground
Fathallah-Shaykh and McIntire
Arch Neurol 1998;55:905-906.
FULL TEXT
|
